gabapentin and pregabalin on neuropathy caused by Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Phase 2
- Conditions
- Chronic inflammatory demyelinating polyneuropathy.Inflammatory polyneuropathy
- Registration Number
- IRCT20200217046523N16
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
CIDP-induced neuropathy based on neurologist diagnosis
Age over 18 years
No other underlying disease that causes neuropathy
Satisfaction with participation in this study
Exclusion Criteria
Hypersensitivity to venlafaxine, gabapentin and pregabalin
Dissatisfaction with continuing the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intensity of patients' body pain. Timepoint: Before the intervention and once every three months for a year. Method of measurement: Visual Analogue Scale.;Severity of neuropathic pain. Timepoint: Before the intervention and once every three months for a year. Method of measurement: Short form of McGill Pain Questionnaire (SF-MPQ).
- Secondary Outcome Measures
Name Time Method